U.S. Patents Awarded to Inventors in California (Feb. 3)

(Targeted News Service Via Acquire Media NewsEdge) Targeted News Service Targeted News Service ALEXANDRIA, Va., Feb. 3 -- The following federal patents were awarded to inventors in California.

*** Lam Research Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Lam Research, Fremont, Calif., has been assigned a patent (8,361,564) developed by Andrew R. Romano, Pleasanton, Calif., and S.M. Reza Sadjadi, Saratoga, Calif., for a "protective layer for implant photoresist." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method for implanting a dopant in a substrate is provided. A patterned photoresist mask is formed over the substrate, wherein the patterned photoresist mask has patterned photoresist mask features. A protective layer is deposited on the patterned photoresist mask by performing a cyclical deposition, wherein each cycle, comprises a depositing phase for depositing a deposition layer over surfaces of the patterned mask of photoresist material and a profile shaping phase for providing vertical sidewalls. A dopant is implanted into the substrate using an ion beam. The protective layer and photoresist mask are removed." The patent application was filed on Dec. 19, 2008 (12/339,514). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,361,564&OS=8,361,564&RS=8,361,564 Written by Arpi Sharma; edited by Anand Kumar.

*** Unity Semiconductor Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Unity Semiconductor, Sunnyvale, Calif., has been assigned a patent (8,361,560) developed by Robin Cheung, Cupertino, Calif., and Wen Zhong Kong, Newark, Calif., for an "immersion platinum plating solution." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A platinum plating solution for immersion plating a continuous film of platinum on a metal structure. The immersion platinum plating solution is free of a reducing agent. The plating process does not require electricity (e.g., electrical current) and does not require electrodes (e.g., anode and/or cathode). The solution includes a platinum source and a complexing agent including Oxalic Acid. The solution enables immersion plating of platinum onto a metal surface, a metal substrate, or a structure of which at least a portion is a metal. The resulting platinum plating comprises a continuous thin film layer of platinum having a thickness not exceeding 300 .ANG.. The solution can be used for plating articles including but not limited to jewelry, medical devices, electronic structures, microelectronics structures, MEMS structures, nano-sized or smaller structures, structures used for chemical and/or catalytic reactions (e.g., catalytic converters), and irregularly shaped metal surfaces." The patent application was filed on Aug. 16, 2012 (13/587,774). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,361,560&OS=8,361,560&RS=8,361,560 Written by Arpi Sharma; edited by Anand Kumar.

*** Applied Materials Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Applied Materials, Santa Clara, Calif., has been assigned a patent (8,361,549) developed by six co-inventors for a "power loading substrates to reduce particle contamination." The co-inventors are Dong-Kil Yim, Sungnam, South Korea, John M. White, Hayward, Calif., Soo Young Choi, Fremont, Calif., Han Byoul Kim, Chon An, South Korea, Jin Man Ha, Yuseong-gu, South Korea, and Beom Soo Park, San Jose, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method for preventing particle contamination within a processing chamber is disclosed. Preheating the substrate within the processing chamber may cause a thermophoresis effect so that particles within the chamber that are not adhered to a surface may not come to rest on the substrate. One method to increase the substrate temperature is to plasma load the substrate. Plasma loading comprises providing an inert gas plasma to the substrate to heat the substrate. Another method to increase the substrate temperature is high pressure loading the substrate. High pressure loading comprises heating the substrate while increasing the chamber pressure to between about 1 Torr and about 10 Torr. By rapidly increasing the substrate temperature within the processing chamber prior to substrate processing, particle contamination is less likely to occur." The patent application was filed on Dec. 9, 2011 (13/315,366). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,361,549&OS=8,361,549&RS=8,361,549 Written by Arpi Sharma; edited by Anand Kumar.

*** Hewlett-Packard Development Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Hewlett-Packard Development, Houston, has been assigned a patent (8,361,572) developed by Christopher Toles, Escondido, Calif., Xi Zeng, San Diego, and Jason Swei, San Diego, for a "coated medium for inkjet printing." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A coated medium for inkjet printing, which includes a supporting substrate and a coating layer formed on at least one side thereof. The coating layer includes at least one binder and at least two different inorganic pigments: modified calcium carbonate (MCC) and either precipitated calcium carbonate (PCC) or clay." The patent application was filed on Oct. 30, 2009 (12/609,746). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,361,572&OS=8,361,572&RS=8,361,572 Written by Arpi Sharma; edited by Anand Kumar.

*** Intel Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Intel, Santa Clara, Calif., has been assigned a patent (8,361,594) developed by five co-inventors for "methods of forming magnetic vias to maximize inductance in integrated circuits and structures formed thereby." The co-inventors are Donald Gardner, Mountain View, Calif., Gerhard Schrom, Hillsboro, Ore., Peter Hazucha, Beaverton, Ore., Fabrice Paillet, Hillboro, Ore., and Tanay Karnik, Portland, Ore.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Methods and associated structures of forming microelectronic devices are described. Those methods may include forming a first layer of a magnetic material on a substrate, forming an oxide layer on the first layer of the magnetic material, forming at least one conductive structure on the first magnetic layer, forming a dielectric layer on the at least one conductive structure, forming a second layer of the magnetic material on the at least one conductive structure, and forming a magnetic via coupled to the first and second layers of the magnetic material, wherein the magnetic via comprises a shape to increase inductance of the inductive structure." The patent application was filed on Nov. 7, 2007 (11/936,724). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,361,594&OS=8,361,594&RS=8,361,594 Written by Arpi Sharma; edited by Anand Kumar.

*** Illumina Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Illumina, San Diego, has been assigned a patent (8,361,713) developed by five co-inventors for a "system and apparatus for sequential processing of analytes." The co-inventors are John Bridgham, Hillsborough, Calif., Kevin Corcoran, Fremont, Calif., George Golda, El Granada, Calif., Michael C. Pallas, San Bruno, Calif., and Sydney Brenner, Cambridge, United Kingdom.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "An apparatus and system are provided for simultaneously analyzing a plurality of analytes anchored to microparticles. Microparticles each having a uniform population of a single kind of analyte attached are disposed as a substantially immobilized planar array inside of a flow chamber where steps of an analytical process are carried out by delivering a sequence of processing reagents to the microparticles by a fluidic system under microprocessor control. In response to such process steps, an optical signal is generated at the surface of each microparticle which is characteristic of the interaction between the analyte carried by the microparticle and the delivered processing reagent. The plurality of analytes are simultaneously analyzed by collecting and recording images of the optical signals generated by all the microparticles in the planar array. A key feature of the invention is the correlation of the sequence of optical signals generated by each microparticle in the planar array during the analytical process." The patent application was filed on Oct. 12, 2007 (11/974,239). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,361,713.PN.&OS=PN/8,361,713&RS=PN/8,361,713 Written by Kusum Sangma; edited by Anand Kumar.

*** California Institute of Technology, University of Southern California Assigned Patent ALEXANDRIA, Va., Feb. 3 -- California Institute of Technology, Pasadena, Calif., and the University of Southern California, Los Angeles, have been assigned a patent (8,361,738) developed by Emil P. Kartalov, Pasadena, Calif., Axel Scherer, Laguna Beach, Calif., and Clive Taylor, Malibu, Calif., for "methods for quantitative target detection and related devices and systems." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Described herein is a method for detection of a target in a sample and related devices and systems." The patent application was filed on March 4, 2010 (12/717,402). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,361,738.PN.&OS=PN/8,361,738&RS=PN/8,361,738 Written by Kusum Sangma; edited by Anand Kumar.

*** Stanford University Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Stanford University, Palo Alto, Calif., has been assigned a patent (8,361,736) developed by Ravindra Majeti, Stanford, Calif., and Irving L. Weissman, Stanford, Calif., for an "ex vivo methods for targeting or depleting acute myeloid leukemia cancer stem cells." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Markers of acute myeloid leukemia stem cells (AMLSC) are identified. The markers are differentially expressed in comparison with normal counterpart cells, and are useful as diagnostic and therapeutic targets." The patent application was filed on July 14, 2010 (12/836,152). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,361,736.PN.&OS=PN/8,361,736&RS=PN/8,361,736 Written by Kusum Sangma; edited by Anand Kumar.

*** Senomyx Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Senomyx, San Diego, has been assigned a patent (8,361,729) developed by five co-inventors for a "detection of cells expressing T1R2 taste receptor." The co-inventors are Jon Elliot Adler, San Diego, Xiaodong Li, San Diego, Lena Staszewski, San Diego, Shawn O'Connell, Encinitas, Calif., and Sergey Zozulya, San Diego.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Binding assays for identifying compounds that modulate human T1R2 polypeptide associated taste are disclosed. These assays detect the specific binding of compounds to a human T1R2 polypeptide or the modulation of the specific binding of a compound that specifically binds to a human T1R2 polypeptide. The binding assays may include the use of detectable labels, e.g., radionuclides, enzymes, fluorophases, and the like. Compounds identified in these binding assays have putative application as T1R2 taste modulators, particularly sweet taste, and potentially are useful additives in compositions for human or animal consumption." The patent application was filed on Feb. 10, 2012 (13/370,978). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,361,729.PN.&OS=PN/8,361,729&RS=PN/8,361,729 Written by Kusum Sangma; edited by Anand Kumar.

*** Electronvault Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Electronvault, Woodside, Calif., has been assigned a patent (8,361,646) developed by Robert R. Ferber Jr., Woodside, Calif., for a modular interconnection system.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A modular interconnection system in the form of a releasable modular interconnect is provided. The releasable modular interconnect may include a substrate with a plurality of releasable contact regions, where each releasable contact region may be positioned to overlay a respective terminal of a power cell. The releasable modular interconnect may also include at least one conductive interconnect member affixed to the substrate, where the conductive interconnect member includes at least a one conductive releasable contact disposed within a releasable contact region of the substrate. The conductive releasable contact may be positioned to form a releasable electrical connection with a terminal of a power cell when a force is applied to the first releasable contact region in a direction toward the terminal of the power cell. Additional and related methods and apparatuses are also provided." The patent application was filed on March 15, 2010 (12/724,388). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,361,646.PN.&OS=PN/8,361,646&RS=PN/8,361,646 Written by Kusum Sangma; edited by Anand Kumar.

*** Stanford University Assigned Patent for Keratin 8 Mutations are Risk Factors for Developing Liver Disease of Multiple Etiologies ALEXANDRIA, Va., Feb. 3 -- Stanford University, Palo Alto, Calif., has been assigned a patent (8,361,723) developed by M. Bishr Omary, Ann Arbor, Mich., and Nam-On Ku, Palo Alto, Calif., for a "keratin 8 mutations are risk factors for developing liver disease of multiple etiologies." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Keratin 8 and 18 (K8/K18) mutations are shown to be associated with a predisposition to liver or biliary tract disease, particularly noncryptogenic hepatobiliary disease. Unique K8/K18 mutations are shown in patients with diseases including but without limitation to viral hepatitis, biliary atresia, alcoholic cirrhosis and other acute or chronic toxic liver injury, cryptogenic cirrhosis, acute fulminant hepatitis, autoimmune liver disease, cystic fibrosis, primary biliary cirrhosis, primary sclerosing cholangitis, diseases that are linked with cryptogenic cirrhosis, such as nonalcoholic steatohepatitis, and the like. Livers with keratin mutations had increased incidence of cytoplasmic filamentous deposits. Therefore, K8/K18 are susceptibility genes for developing cryptogenic and noncryptogenic forms of liver disease. Mutant alleles are associated with disease susceptibility, and their detection is used in the diagnosis of a predisposition to these conditions." The patent application was filed on Oct. 20, 2010 (12/908,548). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,361,723.PN.&OS=PN/8,361,723&RS=PN/8,361,723 Written by Kusum Sangma; edited by Anand Kumar.

*** PolyPlus Battery Assigned Patent ALEXANDRIA, Va., Feb. 3 -- PolyPlus Battery, Berkeley, Calif., has been assigned a patent (8,361,664) developed by four co-inventors for a "protected lithium electrode fuel cell system incorporating a PEM fuel cell." The co-inventors are Steven J. Visco, Berkeley, Calif., Yevgeniy S. Nimon, Danville, Calif., Bruce D. Katz, Orinda, Calif., and Lutgard C. De Jonghe, Lafayette, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Active metal fuel cells are provided. An active metal fuel cell has a renewable active metal (e.g., lithium) anode and a cathode structure that includes an electronically conductive component (e.g., a porous metal or alloy), an ionically conductive component (e.g., an electrolyte), and a fluid oxidant (e.g., air, water or a peroxide or other aqueous solution). The pairing of an active metal anode with a cathode oxidant in a fuel cell is enabled by an ionically conductive protective membrane on the surface of the anode facing the cathode." The patent application was filed on July 13, 2011 (13/182,322). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,361,664.PN.&OS=PN/8,361,664&RS=PN/8,361,664 Written by Kusum Sangma; edited by Anand Kumar.

*** Naturon Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Naturon, New Canaan, Conn., has been assigned a patent (8,361,734) developed by five co-inventors for a "xanthurenic acid derivative pharmaceutical compositions and methods related thereto." The co-inventors are Neal Bricker, Claremont, Calif., Stewart Shankel, Redlands, Calif., Christopher D. Cain, Redlands, Calif., Mark Mitchnick, East Hampton, N.Y., and Michael Schmertzler, New Canaan, Conn.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to diuretic pharmaceutical compositions and methods and in particular to certain derivatives of the formula I: ##STR00001## or a prodrug or pharmaceutically acceptable salt thereof; and a pharmaceutically acceptable carrier." The patent application was filed on Oct. 10, 2011 (13/269,843). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,361,734.PN.&OS=PN/8,361,734&RS=PN/8,361,734 Written by Kusum Sangma; edited by Anand Kumar.

*** Pellion Technologies Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Pellion Technologies, Cambridge, Mass., has been assigned a patent (8,361,661) developed by Robert Ellis Doe, Brighton, Mass., George Earl Blomgren, Lakewood, Ohio, and Kristin Aslaug Persson, Orinda, Calif., for a "rechargeable magnesium ion cell components and assembly." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A magnesium battery electrode assembly is described, including a current collector comprising a carbonaceous material and an electrode layer comprising an electrode active material disposed on the current collector." The patent application was filed on March 8, 2011 (13/043,296). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,361,661.PN.&OS=PN/8,361,661&RS=PN/8,361,661 Written by Kusum Sangma; edited by Anand Kumar.

*** SiPix Imaging Assigned Patent ALEXANDRIA, Va., Feb. 3 -- SiPix Imaging, Fremont, Calif., has been assigned a patent (8,361,620) developed by six co-inventors for a "functionalized halogenated polymers for microencapsulation." The co-inventors are Hongmei Zang, Sunnyvale, Calif., Huiyong Paul Chen, San Jose, Calif., Mahmoud-Zohdi Armoush, Santa Clara, Calif., Denis Leroux, Salem, Mass., Rongchi Yu, Glenmont, N.Y., and Rong-Chang Liang, Cupertino, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention is directed to a novel reactive protective colloid system suitable for stabilizing an electrophoretic display in which a halogenated solvent, particularly a fluorinated, more particularly a perfluorinated, solvent, or a mixture thereof, is used as the dielectric solvent." The patent application was filed on Feb. 13, 2006 (11/353,374). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,361,620.PN.&OS=PN/8,361,620&RS=PN/8,361,620 Written by Kusum Sangma; edited by Anand Kumar.

*** Genentech Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Genentech, South San Francisco, Calif., has been assigned a patent (8,361,744) developed by Matthew Marrichi, Irvine, Calif., and Dorothea E. Reilly, San Francisco, for "methods and composition for secretion of heterologous polypeptides." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates generally to the fields of molecular biology and protein technology. More specifically, the invention concerns signal sequences for the secretion of heterologous polypeptide from bacteria. The invention also concerns recombinant polypeptides and uses thereof." The patent application was filed on Nov. 5, 2010 (12/940,825). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,361,744.PN.&OS=PN/8,361,744&RS=PN/8,361,744 Written by Kusum Sangma; edited by Anand Kumar.

*** University of California Assigned Patent ALEXANDRIA, Va., Feb. 3 -- The University of California, Oakland, Calif., has been assigned a patent (8,361,733) developed by David Julius, San Francisco, David D. McKemy, Livermore, Calif., and Werner M. Neuhausser, San Francisco, for "methods of identifying modulators of a cold-and-menthol-sensitive receptor (CMR1) and recombinant cells for use thereof." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to regulation of cold sensation and pain. More particularly, the present invention is directed to nucleic acids encoding a member of the transient regulatory protein family, CMR1, which is involved in modulation of the perception of cold sensations and pain. The invention further relates to methods for identifying and using agents that modulate cold responses and pain responses stimulated by cold via modulation of CMR1 and CMR1-related signal transduction." The patent application was filed on Oct. 14, 2010 (12/905,001). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,361,733.PN.&OS=PN/8,361,733&RS=PN/8,361,733 Written by Kusum Sangma; edited by Anand Kumar.

*** Life Technologies Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Life Technologies, Carlsbad, Calif., has been assigned a patent (8,361,735) developed by Michael J. Eck, Walnut Creek, Calif., for an "interference control panel for evaluation of analytical assays for samples derived from blood." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention relates to quality control of analytical assays, particularly NAT assays of blood samples containing nucleic acids. A control panel containing quantified amounts of substances known to interfere with an analytical assay is used and compared with a reference sample in the analytical assay. A comparison of the assay results interference panel validates the assay and can serve as a periodic quality control check for the analytical assay as well as related methods and protocols. The use of the control panel of the invention can also determine whether interfering substances are present and establish under what conditions the analytical assay reliable." The patent application was filed on Nov. 29, 2011 (13/306,543). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,361,735.PN.&OS=PN/8,361,735&RS=PN/8,361,735 Written by Kusum Sangma; edited by Anand Kumar.

*** INSERM, University of California, Universite Paris Diderot-Paris 7 Assigned Patent ALEXANDRIA, Va., Feb. 3 -- INSERM (Institut National de la Sante et de la Recherche Medicale, Paris, the University of California, Oakland, Calif., and Universite Paris Diderot-Paris 7, Paris, have been assigned a patent (8,361,732) developed by four co-inventors for a "combination of sPLA2 activity and oxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event." The co-inventors are Ziad Mallat, Herbeville, France, Alain Tedgui, Paris, Sotirios Tsimikas, San Diego, and Joseph Witztum, San Diego.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The use of a combination of sPLA2 activity and OxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event or for the monitoring of a cardiovascular disease." The patent application was filed on March 9, 2012 (13/416,014). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,361,732.PN.&OS=PN/8,361,732&RS=PN/8,361,732 Written by Kusum Sangma; edited by Anand Kumar.

*** Tesla Motors Assigned Patent for Battery Pack Enclosure with Controlled Thermal Runaway Release System ALEXANDRIA, Va., Feb. 3 -- Tesla Motors, Palo Alto, Calif., has been assigned a patent (8,361,642) developed by Weston Arthur Hermann, Palo Alto, Calif., Alex Prilutsky, San Mateo, Calif., and Vineet Haresh Mehta, Mountain View, Calif., for a "battery pack enclosure with controlled thermal runaway release system." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A battery pack thermal management system is provided that is comprised of at least one enclosure failure port integrated into at least one wall of a battery pack enclosure, where the enclosure failure port(s) remains closed during normal operation of the battery pack, and opens during a battery pack thermal runaway event, thereby providing a flow path for hot gas generated during the thermal runaway event to be exhausted out of the battery pack enclosure in a controlled fashion." The patent application was filed on Aug. 15, 2012 (13/586,010). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,361,642.PN.&OS=PN/8,361,642&RS=PN/8,361,642 Written by Kusum Sangma; edited by Anand Kumar.

*** Tesla Motors Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Tesla Motors, Palo Alto, Calif., has been assigned a patent (8,361,649) developed by four co-inventors for a "method and apparatus for maintaining cell wall integrity using a high yield strength outer casing." The co-inventors are Weston Arthur Hermann, Palo Alto, Calif., Vineet Haresh Mehta, Mountain View, Calif., Alex Prilutsky, San Mateo, Calif., and Scott Ira Kohn, Redwood City, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A method and apparatus is provided in which a pre-formed secondary can comprised of one or more layers of a high yield strength material is positioned around the pre-formed battery case, the pre-formed secondary can inhibiting the flow of hot, pressurized gas from within the battery through perforations formed in the battery casing during a thermal runaway event." The patent application was filed on Aug. 13, 2012 (13/572,723). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO1&Sect2=HITOFF&d=PALL&p=1&u=%2Fnetahtml%2FPTO%2Fsrchnum.htm&r=1&f=G&l=50&s1=8,361,649.PN.&OS=PN/8,361,649&RS=PN/8,361,649 Written by Kusum Sangma; edited by Anand Kumar.

*** Yield Engineering Systems Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Yield Engineering Systems, Livermore, Calif., has been assigned a patent (8,361,548) developed by William A. Moffat, San Jose, Calif., and Kenneth M. Sautter, Sunnyvale, Calif., for a "method for efficient coating of substrates including plasma cleaning and dehydration." The abstract of the patent published by the U.S. Patent and Trademark Office states: "A process for the coating of substrates comprising insertion of a substrate into a process oven, plasma cleaning of the substrate, rehydration of the substrate, dehydration of the substrate, withdrawal of a metered amount of one or more chemicals from one or more chemical reservoirs, vaporizing the withdrawn chemicals in one or more vapor chambers, and transfer of the vaporized chemicals into a process oven, thereby reacting with the substrate. An apparatus for the coating of substrates comprising a process oven, a gas plasma generator, a metered chemical withdrawal subsystem, and a vaporization subsystem." The patent application was filed on Aug. 20, 2008 (12/229,307). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,361,548&OS=8,361,548&RS=8,361,548 Written by Arpi Sharma; edited by Anand Kumar.

*** Abbott Laboratories Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Abbott Laboratories, Abbott Park, Ill., has been assigned a patent (8,361,538) developed by Stephen Pacetti, San Jose, Calif., for "methods for applying an application material to an implantable device." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Devices and methods for applying a coating to an implantable device are disclosed. A method for applying a coating to an implantable device is disclosed. The method includes positioning an implantable device relative to an ultrasonic material delivery apparatus. The ultrasonic material delivery apparatus includes an ultrasonic generator. At least one of the ultrasonic material delivery apparatus and the implantable device has a positive or negative electric charge. An application material is applied to the implantable device using the ultrasonic material delivery apparatus." The patent application was filed on Dec. 9, 2008 (12/331,290). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,361,538&OS=8,361,538&RS=8,361,538 Written by Arpi Sharma; edited by Anand Kumar.

*** Ocugenics Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Ocugenics, Orangevale, Calif., has been assigned a patent (8,361,492) developed by six co-inventors for a "drug delivery system and methods of use." The co-inventors are Shachar Tauber, Ozark, Mo., Randall Fuerst, Orangevale, Calif., Keela Davis, Springfield, Mo., Lyle Bowman, Pleasanton, Calif., Gary Wnek, Cleveland, and Joseph J. Bango Jr., New Haven, Conn.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Electrospun fibers are utilized to improve the mechanical characteristics of a contact lens reducing the weight and mechanical strength of the polymers from which the lenses are typically formed. Electrospun fibers are also utilized as a drug delivery system, both through direct use in the eye and by inclusion of the fibers in a contact lens. The fibers are loaded with therapeutic drugs by a variety of methods and processed by coating and cross-linking the fibers." The patent application was filed on June 24, 2009 (12/490,972). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,361,492&OS=8,361,492&RS=8,361,492 Written by Arpi Sharma; edited by Anand Kumar.

*** K-PAX Vitamins Assigned Patent ALEXANDRIA, Va., Feb. 3 -- K-PAX Vitamins, Mill Valley, Calif., has been assigned a patent (8,361,512) developed by Jon D. Kaiser, Mill Valley, Calif., for a "nutrient compositions and methods for enhanced effectiveness of the immune system." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Provided are methods and compositions for increasing CD4.sup.+ cell count in mammals, preferably by at least 25%, while undergoing treatment for various conditions whose treatment can have detrimental effects on immune system function. Such conditions include, but are not limited to, HIV infection, cancer, and hepatitis. The compositions include alpha lipoic acid; acetyl L-carnitine; N-acetyl-cysteine; zinc; selenium; vitamin C; bioflavinoid complex; vitamin E; optionally one or more antioxidants selected from co-enzyme Q10 and glutathione; and one or more vitamins or minerals selected from beta-carotene, vitamin A, vitamin B1, vitamin B2, vitamin B6, niacinamide, calcium pantothenate, folic acid, vitamin B12, copper, manganese, chromium, and molybdenum." The patent application was filed on May 27, 2011 (13/117,811). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,361,512&OS=8,361,512&RS=8,361,512 Written by Arpi Sharma; edited by Anand Kumar.

*** Advanced Cardiovascular Systems Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Advanced Cardiovascular Systems, Santa Clara, Calif., has been assigned a patent (8,361,539) developed by five co-inventors for "methods of forming microparticle coated medical device." The co-inventors are Steven Z. Wu, Santa Clara, Calif., Syed F.A. Hossainy, Fremont, Calif., Sameer Harish, Fremont, Calif., Deborra Sanders-Millare, San Jose, Calif., and Daryush Mirzaee, Sunnyvale, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "A drug-loaded microparticle is applied to a medical device for subsequent application to biological tissues. A method of formulating a drug-loaded microparticle and applying it to the surface of a medical device, such as a stent, is disclosed. The drug-loaded microparticle is formulated by combining a drug with various chemical solutions. Specified sizes of the microparticles and amounts of drug(s) contained within the microparticles may be varied by altering the proportions of the chemicals/solutions. In addition to various drugs, therapeutic substances and radioactive isotopes may also be loaded into the microparticles. The drug-loaded microparticle are suspended in a polymer solution forming a polymer matrix. The polymer matrix may be applied to the entire surface or only selected portions of the medical device via dipping, spraying or combinations thereof." The patent application was filed on Sept. 15, 2003 (10/663,181). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,361,539&OS=8,361,539&RS=8,361,539 Written by Arpi Sharma; edited by Anand Kumar.

*** MacroGenics West Assigned Patent ALEXANDRIA, Va., Feb. 3 -- MacroGenics West, South San Francisco, Calif., has been assigned a patent (8,361,475) developed by Jennie P. Mather, Millbrae, Calif., and Deryk T. Loo, Belmont, Calif., for an ADAM-9 modulators.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention provides the identification and characterization of a disease and cancer-associated antigen, KID24. The invention also provides modulators of KID24, including a family of monoclonal antibodies that bind to antigen KID24, and methods of diagnosing and treating various human cancers and diseases with KID24." The patent application was filed on Jan. 14, 2010 (12/687,512). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,361,475&OS=8,361,475&RS=8,361,475 Written by Arpi Sharma; edited by Anand Kumar.

*** Lpath Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Lpath, San Diego, has been assigned a patent (8,361,465) developed by Roger A. Sabbadini, Lakeside, Calif., and William A. Garland, San Clemente, Calif., for a "use of anti-sphingosine-1-phosphate antibodies in combination with chemotherapeutic agents." The abstract of the patent published by the U.S. Patent and Trademark Office states: "The present invention relates to use of anti-S1P antibodies in combination with chemotherapeutic agents for treatment and/or prevention of cancer, tumor growth, metastasis and/or growth of metastatic tumors." The patent application was filed on Jan. 19, 2010 (12/690,033). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,361,465&OS=8,361,465&RS=8,361,465 Written by Arpi Sharma; edited by Anand Kumar.

*** International Business Machines, Agency for Science, Technology and Research Assigned Patent ALEXANDRIA, Va., Feb. 3 -- International Business Machines, Armonk, N.Y., and Agency for Science, Technology and Research, Singapore, have been assigned a patent (8,361,495) developed by James Lupton Hedrick, Pleasanton, Calif., Kazuki Fukushima, San Jose, Calif., and Yi Yan Yang, Singapore, for an "atimicrobial polymers and methods of manufacture thereof." The abstract of the patent published by the U.S. Patent and Trademark Office states: "Biodegradable cationic block copolymers are disclosed, comprising a hydrophilic block comprising first repeat units derived from a first cyclic carbonyl monomer by ring-opening polymerization, wherein more than 0% of the first repeat units comprise a side chain moiety comprising a quaternary amine group; a hydrophobic block comprising second repeat units derived from a second cyclic carbonyl monomer by ring-opening polymerization; an optional endcap group; and a chain fragment derived from an initiator for the ring opening polymerization. The cationic block copolymers form aqueous micelle mixtures suitable for antimicrobial applications." The patent application was filed on Dec. 23, 2009 (12/646,071). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,361,495&OS=8,361,495&RS=8,361,495 Written by Arpi Sharma; edited by Anand Kumar.

*** GP Medical, National Tsing Hua University Assigned Patent ALEXANDRIA, Va., Feb. 3 -- GP Medical, Newport Beach, Calif., and National Tsing Hua University, Hsinchu, Taiwan, have been assigned a patent (8,361,439) developed by six co-inventors for a "pharmaceutical composition of nanoparticles." The co-inventors are Hsing-Wen Sung, Hsinchu, Taiwan, Kiran Sonaje, Hsinchu, Taiwan, Zi-Xian Liao, Hsinchu, Taiwan, Ha Giang Thi Nguyen, Hsinchu, Taiwan, Er-Yuan Chuang, Hsinchu, Taiwan, and Hosheng Tu, Newport Beach, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "The invention discloses a pharmaceutical composition of bioactive nanoparticles composed of chitosan, poly-glutamic acid, and a bioactive agent for oral delivery. The chitosan-based nanoparticles are characterized with a positive surface charge and enhanced permeability for oral drug delivery." The patent application was filed on Aug. 20, 2012 (13/589,934). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,361,439&OS=8,361,439&RS=8,361,439 Written by Arpi Sharma; edited by Anand Kumar.

*** Hearthside Food Solutions Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Hearthside Food Solutions, Downers Grove, Ill., has been assigned a patent (8,361,528) developed by four co-inventors for a "flake cereal or chip and method for making same." The co-inventors are Larry Donald Schopf, Madison, Wis., Bryan Jarel Streety, Salem, Ore., Guru Hari Singh Khalsa, Eugene, Ore., and Peter Hynding Mattson, Hillsborough, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Embodiments of the present invention provide a flake having a high level of whole grains, such as oat groats, nuts and/or other particulate. An embodiment of the present invention provides a flake having a low degree of degradation giving the flake a granola appearance and texture, a relatively large thickness of the flake, which further contributes to the appearance and the crunchy texture, and/or uses a low degree of cook to the binding constituent that provides the high viscosity for binding and a resultant crunchy texture." The patent application was filed on Jan. 29, 2008 (12/021,661). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,361,528&OS=8,361,528&RS=8,361,528 Written by Arpi Sharma; edited by Anand Kumar.

*** Aadvantics Pharmaceuticals Assigned Patent ALEXANDRIA, Va., Feb. 3 -- Aadvantics Pharmaceuticals, Coto De Caza, Calif., has been assigned a patent (8,361,519) developed by Brian M. Levine, Coto De Caza, Calif., and William E. Berger, Coto De Caza, Calif., for a "combination herbal product to benefit respiratory tract in people exposed to smoke." The abstract of the patent published by the U.S. Patent and Trademark Office states: "An herbal composition for providing a beneficial effect to the respiratory tract. The composition includes Thyme Leaf, Wild Cherry Bark, Cocoa Extract, Mullein Leaf Extract, and Boswellia Serrata. In particular, the composition may prevent or treat cough, specifically caused by exposure to smoke. Also described are methods of using the herbal composition." The patent application was filed on Nov. 16, 2011 (13/297,534). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,361,519&OS=8,361,519&RS=8,361,519 Written by Arpi Sharma; edited by Anand Kumar.

*** SkinMedica Assigned Patent ALEXANDRIA, Va., Feb. 3 -- SkinMedica, Carlsbad, Calif., has been assigned a patent (8,361,485) developed by nine co-inventors for a "conditioned cell culture medium compositions and methods of use." The co-inventors are Gail K. Naughton, Del Mar, Calif., David L. Horwitz, San Diego, Mark A. Applegate, San Diego, Joan Zeltinger, San Diego, Jonathan N. Mansbridge, La Jolla, Calif., Andreas Kern, San Diego, Lee K. Landeen, San Diego, Anthony Ratcliffe, Del Mar, Calif., and R. Emmett Pinney, Poway, Calif.

The abstract of the patent published by the U.S. Patent and Trademark Office states: "Novel products comprising conditioned cell culture medium compositions and methods of use are described. The conditioned cell medium compositions of the invention may be comprised of any known defined or undefined medium and may be conditioned using any eukaryotic cell type. The medium may be conditioned by stromal cells, parenchymal cells, mesenchymal stem cells, liver reserve cells, neural stem cells, pancreatic stem cells and/or embryonic stem cells. Additionally, the cells may be genetically modified. A three-dimensional tissue construct is preferred. Once the cell medium of the invention is conditioned, it may be used in any state. Physical embodiments of the conditioned medium include, but are not limited to, liquid or solid, frozen, lyophilized or dried into a powder. Additionally, the medium is formulated with a pharmaceutically acceptable carrier as a vehicle for internal administration, applied directly to a food item or product, formulated with a salve or ointment for topical applications, or, for example, made into or added to surgical glue to accelerate healing of sutures following invasive procedures. Also, the medium may be further processed to concentrate or reduce one or more factors or components contained within the medium." The patent application was filed on Oct. 3, 2006 (11/538,380). The full-text of the patent can be found at http://patft.uspto.gov/netacgi/nph-Parser Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-bool.html&r=1&f=G&l=50&co1=AND&d=PTXT&s1=8,361,485&OS=8,361,485&RS=8,361,485 Written by Arpi Sharma; edited by Anand Kumar.

For more information about Targeted News Service products and services, please contact: Myron Struck, editor, Targeted News Service LLC, Springfield, Va., 703/304-1897; editor@targetednews.com; http://targetednews.com.

-1113112 (c) 2013 Targeted News Service

[ Back To Technology News's Homepage ]